Merck & Co Inc

NYSE: MRK
$99.25
-$0.60 (-0.6%)
Closing Price on January 10, 2025

MRK Articles

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them. ThinkstockPharmaceutical and Biotech investors are about...
The June 30 short interest data have been compared with the previous figures, and across the selected pharmaceutical stocks, short interest decreased.
A new report from UBS highlights three stocks that the firm likes best now. Not only do they all pay a solid dividend and have a good potential for growth, they all could help cushion a portfolio...
thinkstockJune 26, 2015: Markets opened higher on Friday but tech stocks almost immediately dragged down the Nasdaq Composite and eventually weighed on the S&P 500 index as well. A weak report...
The June 15 short interest data have been compared with the previous figures, and for the selected pharmaceutical stocks, short interest is mixed.
thinkstockJune 22, 2015: Markets opened higher on Monday as investors appeared optimistic that Greece and the European Central Bank would strike a deal. That hasn’t happened yet today. Gold dropped...
thinkstockJune 12, 2015: Markets opened lower on Friday as a solution to the Greek-European Union seems to draw further away from negotiators. Energy and healthcare stocks both opened weak and were...
The May 29 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical stocks, short interest is down.
Credit Suisse has updated its autoimmune market model and it sees implications for all of the large cap U.S. pharmaceutical companies in its coverage.
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them. thinkstockJune 2, 2015: Markets opened lower on Tuesday...
The short interest data has been released for the May 15 settlement date and for the selected pharmaceutical stocks, short interest is mixed.
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them. thinkstockMay 22 2015: Markets opened mixed on Friday on...
The April 30 short interest data have been compared with the previous figures, and for the selected pharmaceutical stocks, short interest is mixed.
A new research report from Savita Subramanian and her well-regarded team at Merrill Lynch points out that some of the biggest positive surprises have been from the mega-cap stocks.
In a new report, the RBC team focused on the companies that are making the most progress with treatments for patients with breast cancer.
AI Portfolio

Discover Our Top AI Stocks

Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.

You can follow him investing $500,000 of his own money on our top AI stocks for free.